NCT02933970View on ClinicalTrials.gov

Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals

NACompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

November 1, 2022

Conditions
Hepatitis C
Interventions
OTHER

Telemedicine

Patients will be linked with the provider via two-way video-teleconferencing facilitated by an onsite OAT program staff member

Trial Locations (1)

14216

Andrew H Talal, Buffalo

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Andrew Talal

OTHER

NCT02933970 - Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals | Biotech Hunter | Biotech Hunter